Patents by Inventor Alan L. Greener

Alan L. Greener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7148339
    Abstract: The subject invention provides for a method of selectively cloning homoduplex nucleic acid molecules, in particular, by using a strain of host cells that contains a conditionally expressed and/or conditionally active mismatch-recognizing enzyme, e.g., a temperature sensitive variant of the gene encoding the endonuclease VII from phage T4. Using this host strain, the invention features a novel cloning method that selects for PCR products that are devoid of PCR-generated mutations.
    Type: Grant
    Filed: March 23, 2005
    Date of Patent: December 12, 2006
    Assignee: Stratagene California
    Inventors: Alan L. Greener, Lisa Joy Hexdall, Carsten Peter Carstens, Joseph A. Sorge
  • Patent number: 6869797
    Abstract: This invention provides improved electroporation methods for transferring nucleic acids of interest into host cells, wherein the host cells are (1) suspended in a substantially non-ionic solution comprising at least one sugar or sugar derivative, (2) mixed with the nucleic acids of interest, and (3) electrically treated. Also, this invention provides for kits used in the method for transferring nucleic acids into host cells.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: March 22, 2005
    Assignee: Stratagene California
    Inventors: Alan L. Greener, Bruce D. Jerpseth
  • Publication number: 20040209362
    Abstract: Provided are methods of generating electrocompetent bacterial cells, the methods involving the growth of the cells at hyperosmotic salt concentration. Also provided are methods of producing a transformed cell, methods of producing a recombinant polypeptide, and strains of E. coli that exhibit increased electrotransformation efficiency.
    Type: Application
    Filed: March 19, 2004
    Publication date: October 21, 2004
    Applicant: Stratagene
    Inventor: Alan L. Greener
  • Publication number: 20040137632
    Abstract: This invention provides improved electroporation methods for transferring nucleic acids of interest into host cells, wherein the host cells are (1) suspended in a substantially non-ionic solution comprising at least one sugar or sugar derivative, (2) mixed with the nucleic acids of interest, and (3) electrically treated. Also, this invention provides for kits used in the method for transferring nucleic acids into host cells.
    Type: Application
    Filed: June 30, 2003
    Publication date: July 15, 2004
    Inventors: Alan L. Greener, Bruce D. Jerpseth
  • Publication number: 20040137628
    Abstract: This invention provides methods for producing and selecting host cells that better survive transformation treatment by subjecting host cells to conditions that alter them, subjecting the altered cells to transformation conditions, and selecting host cells that survive the transformation conditions. This invention also provides methods for transferring nucleic acids of interest into host cells, using cells that are better able to survive transformation treatment. Also, this invention provides kits for producing or selecting host cells in transformation treatments, as well as, kits comprising various host cells that may be utilized in transformation experiments.
    Type: Application
    Filed: October 14, 2003
    Publication date: July 15, 2004
    Applicant: Stratagene
    Inventor: Alan L. Greener
  • Publication number: 20040002155
    Abstract: The subject invention provides for a strain of host cells that contains a temperature sensitive variant of the gene encoding the endonuclease VII from phage T4. Using this host strain, the invention features a novel cloning method that selects for PCR products that are devoid of PCR-generated mutations.
    Type: Application
    Filed: June 26, 2002
    Publication date: January 1, 2004
    Applicant: Stratagene
    Inventors: Alan L. Greener, Lisa Joy Hexdall, Carsten-Peter Carstens, Joseph A. Sorge
  • Publication number: 20040002156
    Abstract: The subject invention provides for a method of selectively cloning homoduplex nucleic acid molecules, in particular, by using a strain of host cells that contains a conditionally expressed and/or conditionally active mismatch-recognizing enzyme, e.g., a temperature sensitive variant of the gene encoding the endonuclease VII from phage T4. Using this host strain, the invention features a novel cloning method that selects for PCR products that are devoid of PCR-generated mutations.
    Type: Application
    Filed: September 19, 2002
    Publication date: January 1, 2004
    Applicant: Stratagene
    Inventors: Alan L. Greener, Lisa Joy Hexdall, Carsten-Peter Carstens, Joseph A. Sorge
  • Patent number: 6635457
    Abstract: This invention provides methods for producing and selecting host cells that better survive transformation treatment by subjecting host cells to conditions that alter them, subjecting the altered cells to transformation conditions, and selecting host cells that survive the transformation conditions. This invention also provides methods for transferring nucleic acids of interest into host cells, using cells that are better able to survive transformation treatment. Also, this invention provides kits for producing or selecting host cells in transformation treatments, as well as, kits comprising various host cells that may be utilized in transformation experiments.
    Type: Grant
    Filed: July 26, 2000
    Date of Patent: October 21, 2003
    Assignee: Stratagene
    Inventor: Alan L. Greener
  • Patent number: 6586249
    Abstract: This invention provides improved electroporation methods for transferring nucleic acids of interest into host cells, wherein the host cells are (1) suspended in a substantially non-ionic solution comprising at least one sugar or sugar derivative, (2) mixed with the nucleic acids of interest, and (3) electrically treated. Also, this invention provides for kits used in the method for transferring nucleic acids into host cells.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: July 1, 2003
    Assignee: Stratagene
    Inventors: Alan L. Greener, Bruce D. Jerpseth
  • Publication number: 20030096223
    Abstract: The present invention relates to methods for the identification of polynucleotides that encode cleavable N-terminal signal sequences.
    Type: Application
    Filed: February 28, 2001
    Publication date: May 22, 2003
    Inventors: Alan L. Greener, Hwai Wen Chang, Carsten Peter Carstens
  • Publication number: 20020164804
    Abstract: This invention provides improved electroporation methods for transferring nucleic acids of interest into host cells, wherein the host cells are (1) suspended in a substantially non-ionic solution comprising at least one sugar or sugar derivative, (2) mixed with the nucleic acids of interest, and (3) electrically treated. Also, this invention provides for kits used in the method for transferring nucleic acids into host cells.
    Type: Application
    Filed: January 15, 2002
    Publication date: November 7, 2002
    Applicant: Stratagene
    Inventors: Alan L. Greener, Bruce D. Jerpseth
  • Patent number: 6338965
    Abstract: This invention provides improved electroporation methods for transferring nucleic acids of interest into host cells, wherein the host cells are (1) suspended in a substantially non-ionic solution comprising at least one sugar or sugar derivative, (2) mixed with the nucleic acids of interest, and (3) electrically treated. Also, this invention provides for kits used in the method for transferring nucleic acids into host cells.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: January 15, 2002
    Assignee: Stratagene
    Inventors: Alan L. Greener, Bruce D. Jerpseth
  • Patent number: 6040184
    Abstract: This invention provides improved electroporation methods for transferring nucleic acids of interest into host cells, wherein the host cells are (1) suspended in a substantially non-ionic solution comprising at least one sugar or sugar derivative, (2) mixed with the nucleic acids of interest, and (3) electrically treated. Also, this invention provides for kits used in the method for transferring nucleic acids into host cells.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: March 21, 2000
    Assignee: Stratagene
    Inventors: Alan L. Greener, Bruce D. Jerpseth
  • Patent number: 6017748
    Abstract: Methods and materials for the cloning of DNA, in particular, for the cloning of "unclonable" DNA using genetically engineered host cells. Host cell organisms have been discovered that stabilize and inhibit rearrangement of DNA molecules capable of forming non-standard secondary and tertiary structures. organisms are engineered to contain at least one mutation which inactivates homologous recombination and at least one mutation in a DNA repair pathway. Examples of such DNA pathways include UV repair pathway, the SOS repair pathway, the mismatch repair pathway, the adaptive response pathway, the heat shock response pathway, the osmotic shock response pathway, the repair pathway of alkylation damage, the repair pathway of uracil incorporation into DNA and pathways involved in maintaining DNA superhelicity. The host organisms of this invention are suitable for cloning DNA capable of forming non-standard and tertiary structures such as found in eukaryotic DNA.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: January 25, 2000
    Assignee: Stratagene
    Inventor: Alan L. Greener
  • Patent number: 5707841
    Abstract: The invention provided herein includes gram negative bacteria cells containing a gene encoding an enzyme with carbohydrate degrading activity that had been rendered competent to transformation. Carbohydrate degrading enzymes of interest for use in the invention include alpha-amylase. The competent cells of the subject invention may be frozen so as to provide for prolonged storage. Other aspects of the invention include methods for rendering gram negative bacterial cells, such as E. coli cells competent to transformation. These methods involve the step of transferring a gene encoding an enzyme with carbohydrate degrading activity into E. coli cells and subsequently rendering the cells competent using any of a variety of competency inducing procedures.
    Type: Grant
    Filed: April 18, 1996
    Date of Patent: January 13, 1998
    Assignee: Stratagene
    Inventor: Alan L. Greener
  • Patent number: 5552314
    Abstract: Methods and materials for the cloning of DNA, in particular, for the cloning of "unclonable" DNA using genetically engineered host cells. Host cell organisms have been discovered that stabilize and inhibit rearrangement of DNA molecules capable of forming non-standard secondary and tertiary structures. Organisms are engineered to contain at least one mutation which inactivates homologous recombination and at least one mutation in a DNA repair pathway. Examples of such DNA pathways include UV repair pathway, the SOS repair pathway, the mismatch repair pathway, the adaptive response pathway, the heat shock response pathway, the osmotic shock response pathway, the repair pathway of alkylation damage, the repair pathway of uracil incorporation into DNA and pathways involved in maintaining DNA superhelicity. The host organisms of this invention are suitable for cloning DNA capable of forming non-standard and tertiary structures such as found in eukaryotic DNA.
    Type: Grant
    Filed: May 15, 1995
    Date of Patent: September 3, 1996
    Assignee: Stratagene
    Inventor: Alan L. Greener
  • Patent number: 5512468
    Abstract: The invention provided herein includes gram negative bacteria cells containing a gene encoding an enzyme with carbohydrate degrading activity that had been rendered competent to transformation. Carbohydrate degrading enzymes of interest for use in the invention include alpha-amylase. The competent cells of the subject invention may be frozen so as to provide for prolonged storage.Other aspects of the invention include methods for rendering gram negative bacterial cells, such as E. coli cells competent to transformation. These methods involve the step of transferring a gene encoding an enzyme with carbohydrate degrading activity into E. coli cells and subsequently rendering the cells competent using any of a variety of competency inducing procedures.
    Type: Grant
    Filed: November 22, 1993
    Date of Patent: April 30, 1996
    Assignee: Stratagene
    Inventor: Alan L. Greener